{"id":"W2102541302","doi":"10.1158/0008-5472.can-04-0401","title":"Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Monoclonal antibody; Vascular endothelial growth factor; Medicine; Pharmacodynamics; Antibody; Pharmacology; Kinase insert domain receptor; Monoclonal; Pharmacokinetics; Cancer research; Immunology; Vascular endothelial growth factor A; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005043088,0.0002058985,0.0002656163,0.0001086698,0.0001982204,0.00004045523,0.00033031,0.0001922811,0.0001662397],"category_scores_gemma":[0.0001369609,0.0001834759,0.0002838497,0.000171652,0.0003152429,0.0000105823,0.0001304861,0.0001488503,0.00001027482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001184398,"about_ca_system_score_gemma":0.0007018275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00100513,"about_ca_topic_score_gemma":0.00007223239,"domain_scores_codex":[0.9981091,0.0001339822,0.0002545323,0.0004957129,0.0004333722,0.0005732801],"domain_scores_gemma":[0.9988641,0.00008231815,0.00007979288,0.0003182534,0.0005233,0.0001322229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0013038,0.00008799913,0.006448347,0.0001252668,0.000346946,0.000002080547,0.0001327365,0.0001099856,0.9884257,0.0002761487,0.0003994117,0.002341581],"study_design_scores_gemma":[0.002097618,0.0004725803,0.003483137,0.00008866964,0.0000261344,0.000003467838,0.0001116401,0.00002865826,0.9723178,0.000150643,0.02099168,0.0002279246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927089,0.005669998,0.0003710836,0.0001479528,0.0001187434,0.0004917078,0.0002430809,0.00001105977,0.0002374714],"genre_scores_gemma":[0.9947782,0.003213767,0.000735631,0.00008107295,0.0005110169,0.0002625589,0.00007663391,0.00005812241,0.0002829963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02059227,"threshold_uncertainty_score":0.748193,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.050287313681114,"score_gpt":0.3613734736810439,"score_spread":0.3110861599999299,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}